Concepedia

Sidath Katugampola

SK

10

Publications

780

Citations

10

H-Index

2001

Active since

Affiliations

Addenbrooke's Hospital(Current)

Cancer Research UK

University of Cambridge

Institute of Cancer Research

Pfizer (United Kingdom)

Sidath Katugampola is an author at Addenbrooke's Hospital specializing in medicine, pharmacology, and physiology.

ORCID

Top concepts

Publications per year

2001–2020

10

Publications

10

[<sup>125</sup>I]‐(Pyr<sup>1</sup>)Apelin‐13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man

Sidath Katugampola, Janet J. Maguire, Stewart R. Matthewson et al. · British Journal of Pharmacology · 2001 · 212 citations · Full text

, , +18

[<sup>125</sup>I‐<i>His</i><sup>9</sup>]‐Ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue; up‐regulation of receptors with atherosclerosis

Sidath Katugampola, Zakos Pallikaros, Anthony P. Davenport · British Journal of Pharmacology · 2001 · 190 citations · Full text

Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT<sub>1</sub> receptor antagonist losartan

Sidath Katugampola, Anthony P. Davenport · British Journal of Pharmacology · 2001 · 105 citations · Full text

Profiling of cAMP and cGMP phosphodiesterases in isolated ventricular cardiomyocytes from human hearts: Comparison with rat and guinea pig

William B. Johnson, Sidath Katugampola, Sarah Able et al. · Life Sciences · 2012 · 88 citations

, , +11

A first-in-human first-in-class (FIC) trial of the monocarboxylate transporter 1 (MCT1) inhibitor AZD3965 in patients with advanced solid tumours.

Sarah Halford, Paul S. Jones, Sandra Hirschberg et al. · Journal of Clinical Oncology · 2017 · 54 citations

, , +19

Rows per page

1–5 of 10